Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans

Eur J Clin Invest. 2003 Sep;33(9):758-61. doi: 10.1046/j.1365-2362.2003.01192.x.

Abstract

Background: Bacterial endotoxins can induce the synthesis and release of vascular endothelial growth factor (VEGF), which may alter vascular permeability and cause vascular leakage.

Materials and methods: The effect of acute systemic inflammation on VEGF concentration was measured in healthy males after an intravenous bolus infusion of Escherichia coli endotoxin (lipopolysaccharide, LPS, 20 IU kg-1) in a double-blind, placebo-controlled parallel group study. LPS administration was followed by an infusion of lepirudin (bolus 0.1 mg kg-1, continuous infusion of 0.1 mg kg-1 h-1, n = 12) or saline (n = 12).

Results: Plasma VEGF increased from a mean of 15.1 pg mL-1 to 74.6 pg mL-1 5 h after LPS (P < 0.003). Body temperature, pulse rate, leukcytes, prothrombin fragment 1 + 2 (F1 + 2) and lactoferrin increased and platelets decreased after LPS (P < 0.05). The LPS-induced increase in VEGF was paralleled by the neutrophil cell degranulation marker lactoferrin but not by F1 + 2, and was not affected by lepirudin, which blunted F1 + 2 formation (P < 0.05).

Conclusions: Inflammation-induced activation of leukcytes rather than platelets plays a role in the marked increase in VEGF, which cannot be abrogated by antithrombotic therapy.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adult
  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects
  • Blood Platelets / drug effects
  • Blood Platelets / physiology
  • Double-Blind Method
  • Endothelial Growth Factors / blood*
  • Endotoxins*
  • Escherichia coli*
  • Hirudins / analogs & derivatives*
  • Humans
  • Inflammation / blood*
  • Intercellular Signaling Peptides and Proteins / blood*
  • Leukocytes / drug effects
  • Leukocytes / physiology
  • Lymphokines / blood*
  • Male
  • Recombinant Proteins / therapeutic use
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Anticoagulants
  • Endothelial Growth Factors
  • Endotoxins
  • Hirudins
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • lepirudin